BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 8 December 2023 at 3.30 p.m. (EET)
BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Oili Halonen
____________________________________________
Person subject to the notification requirement
Name: Halonen Oili
Position: Closely associated person
(1):Person Discharging Managerial Responsibilities In Issuer
Name: Halonen Jarmo
Position: Member of the Board
Issuer: BBS Bioactive Bone Substitutes Oyj
LEI: 743700BYSBP0PCR6N767
Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20231208124156_4
____________________________________________
Transaction date: 2023-12-07
Venue not applicable
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: SUBSCRIPTION
Transaction details
(1): Volume: 2,475 Unit price: 0.4 EUR
Aggregated transactions
(1): Volume: 2,475 Volume weighted average price: 0.4 EUR
For more information, please contact:
Juliusz Rakowski, CEO
+358 50 448 5132
juliusz.rakowski@bbs-artebone.fi
Certified Advisor:
Nordic Certified Adviser AB,
+46 70 551 67 29,
info@certifiedadviser.se
BBS in brief
BBS -Bioactive Bone Substitutes Plc is a orthobiology company that started its operations in 2003. We have developed a new product for the treatment of complex bone fractures and bone healing issues. Our goal is to provide next-generation medical products for the treatment of bone injuries in orthopedic surgery. In the pharmaceutical industry, the development and research work require perseverance and courage to innovate. We have a track record of over 20 years in this field. Our company is characterized by expertise, innovation, and dedicated employees who are passionate about their work. Our first developed product, ARTEBONE® Paste, is in the final stages of the CE marking process to enable its commercialization in the EU market. We are based in Oulu with a medical manufacturing facility in Reisjärvi, holding a manufacturing license. The company’s headquarters are in Oulu, and we employ over 20 people.
BBS has been listed on Nasdaq First North Growth Market Finland since February 2018.
More information: www.bbs-artebone.fi
CAMPBELL, Calif., June 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded…
Reinforcing Abu Dhabi's position as a global life science hub ABU DHABI, UAE, June 19,…
SOMERSET, N.J., June 19, 2025 /PRNewswire/ -- ACI Infotech, a tech consulting powerhouse with deep AI,…
The award-winning BridgeInteract patient engagement platform gives Elation customers a turnkey suite of self-service tools…
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body…
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body…